| Building neural representations of habits MS Jog, Y Kubota, CI Connolly, V Hillegaart, AM Graybiel Science 286 (5445), 1745-1749, 1999 | 1016 | 1999 |
| Fear of falling and postural control in Parkinson's disease AL Adkin, JS Frank, MS Jog Movement disorders 18 (5), 496-502, 2003 | 539 | 2003 |
| An update on the diagnosis and treatment of Parkinson disease P Rizek, N Kumar, MS Jog Cmaj 188 (16), 1157-1165, 2016 | 385 | 2016 |
| Multichannel electrode and methods of using same M Jog, S Nikumb US Patent 7,010,356, 2006 | 342 | 2006 |
| A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit MF Beal, D Oakes, I Shoulson, C Henchcliffe, WR Galpern, R Haas, ... JAMA neurology 71 (5), 543-552, 2014 | 251 | 2014 |
| Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study Huntington Study Group TREND-HD Investigators Archives of neurology 65 (12), 1582-1589, 2008 | 230 | 2008 |
| Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study HC Hyson, AM Johnson, MS Jog Movement disorders: official journal of the Movement Disorder Society 17 (6 …, 2002 | 200 | 2002 |
| Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial DA Mendonça, K Menezes, MS Jog Movement disorders: official journal of the Movement Disorder Society 22 (14 …, 2007 | 172 | 2007 |
| Tetrode technology: advances in implantable hardware, neuroimaging, and data analysis techniques MS Jog, CI Connolly, Y Kubota, DR Iyengar, L Garrido, R Harlan, ... Journal of neuroscience methods 117 (2), 141-152, 2002 | 148 | 2002 |
| Canadian guidelines on Parkinson's disease D Grimes, J Gordon, B Snelgrove, I Lim-Carter, E Fon, W Martin, M Wieler, ... The Canadian journal of neurological sciences. Le journal canadien des …, 2012 | 135 | 2012 |
| An evaluation of sensorimotor integration during locomotion toward a target in Parkinson’s disease QJ Almeida, JS Frank, EA Roy, ME Jenkins, S Spaulding, AE Patla, ... Neuroscience 134 (1), 283-293, 2005 | 130 | 2005 |
| A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease A McGarry, M McDermott, K Kieburtz, EA de Blieck, F Beal, K Marder, ... Neurology 88 (2), 152-159, 2017 | 122 | 2017 |
| Chronic acquired hepatocerebral degeneration: case reports and new insights MS Jog, AE Lang Movement Disorders: Official Journal of the Movement Disorder Society 10 (6 …, 1995 | 114 | 1995 |
| Dopaminergic modulation of timing control and variability in the gait of Parkinson's disease QJ Almeida, JS Frank, EA Roy, AE Patla, MS Jog Movement disorders: official journal of the Movement Disorder Society 22 (12 …, 2007 | 103 | 2007 |
| Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: Protocol for a single-centre, randomized, double-blind, placebo-controlled trial CRA Silveira, J MacKinley, K Coleman, Z Li, E Finger, R Bartha, ... BMC neurology 19, 1-10, 2019 | 96 | 2019 |
| Method of fabricating a multichannel electrode M Jog, S Nikumb US Patent 7,756,588, 2010 | 94 | 2010 |
| Loudness perception and speech intensity control in Parkinson's disease JP Clark, SG Adams, AD Dykstra, S Moodie, M Jog Journal of communication disorders 51, 1-12, 2014 | 90 | 2014 |
| Neurological probe and method of using same S Nikumb, C Dinkel, M Jog US Patent 7,853,303, 2010 | 86 | 2010 |
| Towards remote monitoring of Parkinson’s disease tremor using wearable motion capture systems M Delrobaei, S Memar, M Pieterman, TW Stratton, K McIsaac, M Jog Journal of the neurological sciences 384, 38-45, 2018 | 84 | 2018 |
| Spinal cord stimulation therapy for gait dysfunction in advanced Parkinson's disease patients O Samotus, A Parrent, M Jog Movement Disorders 33 (5), 783-792, 2018 | 83 | 2018 |
